Exercise Program During Chemotherapy in Metastatic Colorectal Cancer

Status Terminated

Clinical Trial Summary

This pilot clinical trial studies how well aerobic exercise works in improving quality of life and health-related outcomes in patients with stage IV colorectal cancer undergoing chemotherapy. Aerobic exercise during chemotherapy may improve quality of life and reduce fatigue and inflammation in the blood related to heart disease and diabetes in patients with stage IV colorectal cancer.

Clinical Trial Description

PRIMARY OBJECTIVES:

I. To determine whether a 6-week indoor or outdoor aerobic exercise program is feasible in patients with metastatic colorectal cancer (mCRC) undergoing chemotherapy and to explore patient's preferences for indoor versus (vs.) outdoor exercise.

II. To determine the effects of a 6-week indoor or outdoor aerobic exercise program on cancer-related fatigue and quality of life (QOL) in patients with mCRC.

SECONDARY OBJECTIVES:

I. To determine the effects of a 6-week indoor or outdoor aerobic exercise program on body composition (lean body mass, fat mass, body fat percentage [%]) and biomarkers of systemic inflammation (interleukin-6 [IL-6], tumor necrosis factor alpha [TNF-a], C-reactive protein [CRP]) in patients with mCRC.

TERTIARY OBJECTIVES:

I. To determine the effects of a 6-week exercise program on cardiovascular (CV) function.

OUTLINE:

Patients undergo aerobic exercise sessions consisting of cycling or walking at a low-moderate intensity and progressing to moderate intensity for 30 minutes 2 times a week for up to 8 weeks.

After completion of study treatment, patients are followed up for 6 weeks and at weeks 13, 19, and 31. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03111823
Study type	Interventional
Source	University of Southern California
Contact
Status	Terminated
Phase	N/A
Start date	July 7, 2016
Completion date	July 5, 2018

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01704703` - Study of FOLFIRI + Panitumumab Using Ultra-selection Technology of Patients With Stage IV Colorectal Cancer Refractory to Irinotecan Without Any Mutation on KRAS, PIK3Ca, BRAF and NRAS Genes Detected With Highly Sensitive Techniques	Phase 2
Terminated	`NCT02960282` - Gut Microbiome in Fecal Samples From Patients With Metastatic Cancer Undergoing Chemotherapy or Immunotherapy
Completed	`NCT01998152` - Individualized Nutritional Counselling During Chemotherapy for Colorectal Cancer (COLONUT)	N/A
Not yet recruiting	`NCT06287723` - French Assessment of MRD by Liquid Biopsies in Colorectal With Liver Metastasis Patients (FRENCH.MRD.CRLM)
Completed	`NCT03005002` - Durvalumab and Tremelimumab in Treating Patients With Microsatellite Stable Metastatic Colorectal Cancer to the Liver	Phase 1
Completed	`NCT03095781` - Pembrolizumab and XL888 in Patients With Advanced Gastrointestinal Cancer	Phase 1
Active, not recruiting	`NCT04267575` - Canady Helios Cold Plasma Scalpel Treatment at the Surgical Margin and Macroscopic Tumor Sites	N/A
Recruiting	`NCT03368963` - TAS102 in Combination With NAL-IRI in Advanced GI Cancers	Phase 1/Phase 2
Active, not recruiting	`NCT04670445` - Improving Patient and Caregiver Understanding of Risks and Benefits of Immunotherapy for Advanced Cancer	N/A
Active, not recruiting	`NCT01271582` - Investigation of Association Between UGT1A1 Polymorphisms and Irinotecan Toxicity in Korean Patients	Phase 4
Active, not recruiting	`NCT03800602` - Nivolumab and Metformin in Patients With Treatment Refractory MSS Colorectal Cancer	Phase 2
Recruiting	`NCT05631574` - Study of Covalent Menin Inhibitor BMF-219 in Adult Patients With KRAS Driven Non-Small Cell Lung Cancer, Pancreatic Cancer, and Colorectal Cancer	Phase 1
Completed	`NCT03112668` - Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their Partners	N/A
Terminated	`NCT01550510` - Research Study of IV Vitamin C in Combination With Irinotecan vs Irinotecan Alone for Advanced Colorectal CA	Phase 1/Phase 2
Recruiting	`NCT02919644` - Vaccination With Autologous Dendritic Cells Loaded With Autologous Tumour Homogenate After Curative Resection for Stage IV Colorectal Cancer.	Phase 2
Completed	`NCT03373188` - VX15/2503 and Immunotherapy in Resectable Pancreatic and Colorectal Cancer	Phase 1
Terminated	`NCT04044430` - Encorafenib, Binimetinib, and Nivolumab in Treating Microsatellite Stable BRAF V600E Metastatic Colorectal Cancer	Phase 1
Completed	`NCT05025748` - Ask Questions (ASQ):Implementation of a Communication Intervention	N/A
Completed	`NCT01722903` - Detection of CTCs in Patients Undergoing Surgery for Stage IV Colorectal Cancer	N/A
Completed	`NCT02809716` - High Definition Single Cell Analysis in Colorectal Cancer